Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial.
Naomi E HammondSimon R FinferQiang LiColman TaylorJeremy CohenYaseen ArabiRinaldo BellomoLaurent BillotMeg HarwardChristopher JoyceColin McArthurJohn MyburghAnders PernerDorrilyn RajbhandariAndrew RhodesKelly ThompsonSteve WebbBalasubramanian Venkateshnull nullPublished in: Intensive care medicine (2020)
Approximately one fifth of septic shock survivors report moderate to extreme problems in HRQoL domains at 6 months. Hydrocortisone treatment for septic shock was not associated with improved HRQoL at 6 months. Female gender was associated with worse pain at 6 months.